Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Prostate Cancer and Prostatic Diseases|February 12, 2024
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer careVincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, et al.
Cancer Medicine|June 6, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinomaLetizia Procaccio, Valeria Merz, Morena Fasano, et al.
ESMO Open|August 2, 2017
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)Michele Orditura, Adriano Gravina, Ferdinando Riccardi, et al.
Biomedicines|February 25, 2022
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other GenesAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2024
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patientsGiulia Orsi, Catia Carconi, Paola Ghiorzo, et al.
Breast Cancer Research and Treatment|March 30, 2017
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experienceMariangela Ciccarese, Alessandra Fabi, Luca Moscetti, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
European Urology Oncology|June 3, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter ExperienceGiuseppina Bruno, Maria Iole Natalicchio, Marianna Garofoli, et al.
Cancer Medicine|June 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatmentGuido Giordano, Michele Milella, Matteo Landriscina, et al.
Molecular Cancer Research : MCR|May 23, 2018
Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal CancersAndrea Remo, Erminia Manfrin, Pietro Parcesepe, et al.
Pageof 11